A Trial of Lenvatinib Plus Pembrolizumab in Subjects With Hepatocellular Carcinoma



Status:Recruiting
Conditions:Liver Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:3/13/2019
Start Date:February 15, 2017
End Date:August 31, 2021
Contact:Eisai Medical Information
Email:esi_oncmedinfo@eisai.com

Use our guide to learn which trials are right for you!

An Open-Label Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Subjects With Hepatocellular Carcinoma

This is an open-label Phase 1b study designed to evaluate the tolerability and safety of
lenvatinib in combination with pembrolizumab in participants with hepatocellular carcinoma
(HCC). The Expansion part of the study will evaluate objective response rate and duration of
response by modified Response Evaluation Criteria In Solid Tumors (mRECIST) for HCC and
Response Evaluation Criteria In Solid Tumors (RECIST 1.1) based on independent imaging review
(IIR).


Inclusion Criteria:

- Confirmed diagnosis of hepatocellular carcinoma (HCC)

- HCC for which no other appropriate therapy is available. Note: Expansion Part: No
prior systemic therapy for advanced/unresectable HCC

- Stage B (not applicable for transarterial chemoembolization [TACE]), or stage C based
on Barcelona Clinic Liver Cancer (BCLC) staging system

- At least 1 measurable target lesion according to modified Response Evaluation Criteria
in Solid Tumors (mRECIST)

- Child-Pugh score A

- Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0 to 1

- Total triiodothyronine (T3) or free T3 and free thyroxine (T4) are within normal
limits. (control by thyroid replacement therapy is acceptable.) Participants with T3,
free T3 or free T4 abnormalities at screening who are asymptomatic can be eligible

- Adequately controlled blood pressure

- Adequate renal function

- Adequate bone marrow function

- Adequate blood coagulation function

- Adequate liver function

- Males or females age ≥ 18 years at the time of informed consent

- Voluntary agreement to provide written informed consent and the willingness and
ability to comply with all aspects of the protocol

Exclusion Criteria:

- Prior treatment with lenvatinib or any anti-PD-1, anti-PD-L1, or anti-PD-L2 agent

- Any current brain or subdural metastases

- Active malignancy (except for HCC or definitively treated melanoma in-situ, basal or
squamous cell carcinoma of the skin, or carcinoma in-situ of the cervix) within the
past 36 months

- Any medical or other condition which, in the opinion of the investigator, would
preclude participation in a clinical trial

- Active infection (any infection requiring systemic treatment). Hepatitis B or C
[HBV/HCV] is allowed

- Participants with CNS metastases are not eligible, unless they have completed local
therapy (eg, whole brain radiation therapy [WBRT], surgery or radiosurgery) and have
discontinued the use of corticosteroids for this indication for at least 4 weeks
before starting treatment in this study. Any signs (eg, radiologic) or symptoms of
brain metastases must be stable for at least 4 weeks before starting study treatment
We found this trial at
8
sites
630 W 168th St
New York, New York
212-305-2862
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
?
mi
from
New York, NY
Click here to add this to my saved trials
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
?
mi
from
Boston, MA
Click here to add this to my saved trials
345 St Paul Pl
Baltimore, Maryland 21202
(410) 332-9000
Mercy Medical Center "Mercy Medical Center" is a hospital located in Baltimore, Maryland. The landmark...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Edinburg, Texas 78539
?
mi
from
Edinburg, TX
Click here to add this to my saved trials
1428 Madison Ave
New York, New York 10029
(212) 241-6500
Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai is...
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Pessac,
Click here to add this to my saved trials
San Francisco, California 94115
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
757 Westwood Plaza
Santa Monica, California 90095
?
mi
from
Santa Monica, CA
Click here to add this to my saved trials